BMS launches next generation arthritis treatment Orencia

June 6, 2007
Sales and Marketing

Bristol-Myers Squibb has launched its next generation rheumatoid arthritis treatment Orencia in the UK, offering patients a novel way of …

Bavarian Nordic secures $1.6 billion deal with US government

June 6, 2007
Sales and Marketing

Danish company Bavarian Nordic has secured a massive new contract to provide the US with millions of doses of smallpox …

HCA launches media relations best practice guide

June 5, 2007
Medical Communications

The Healthcare Communications Association has unveiled a new guide to working with the media, the first in a series of …

Product roundup from Datamonitor

June 4, 2007
Sales and Marketing

Celsion completes enrolment in phase I liver cancer studyCelsion has completed its phase I dose escalation study, using ThermoDox, to …

Clew to promote Novartis’ Aclasta

May 31, 2007
Medical Communications

Novartis has appointed Clew Communications to run a pre-launch and launch PR campaign for its new osteoporosis drug.Aclasta (zoledronic acid) …

NICE approves Pfizer’s Champix

May 31, 2007

Pfizer's first-in-class smoking cessation drug Champix has received approval from NICE one month before England's smoking ban comes into effect.Champix …

China’s former medicines regulator sentenced to death

May 31, 2007
Sales and Marketing

The former head of China's medicines regulator has been sentenced to death after being found guilty of taking bribes to …

Genzyme buys cancer specialists Bioenvision

May 31, 2007
Research and Development

Genzyme is to spend $345 million on acquiring specialist pharma company Bioenvision and its oncology portfolio.Genzyme already co-markets with Bioenvision …

Avandia safety concerns hit GSK shares

May 31, 2007
Sales and Marketing

Shares in GSK have taken another hit after news that US prescribers have turned away from diabetes drug Avandia in …

Product roundup from Datamonitor

May 29, 2007
Sales and Marketing

ADHD drug as effective in boys as girls, says ShireUK pharmaceutical company Shire has said that results from a study …

Industry outlines concerns with NICE to Parliament

May 24, 2007

NICE's shortfalls have compromised public confidence in the cost and clinical-effectiveness body, the pharmaceutical industry has told MPs.The comments were …

PCTs ‘overspending’ on prescribing

May 24, 2007

PCTs could save the NHS more than £200 million if they can persuade more GPs to prescribe generically, according to …

Report raises safety concerns over Avandia

May 24, 2007
Sales and Marketing

GlaxoSmithKline has been forced on the defensive after its blockbuster diabetes treatment Avandia was linked to an increased risk of …

The Changing Face of Medical Education

May 23, 2007
Medical Communications, Sales and Marketing medical education

Is Medical Education the new PR?Phil Sheldon, Managing Director, Resolute Communications:Clients are increasingly waking up to the fact that medical …

Charity outlines vision for tackling cancer

May 23, 2007
Sales and Marketing

Cancer Research UK has set out an ambitious list of goals to reach by 2020, which it hopes will inspire …

Pfizer loses heads of research and finance

May 23, 2007
Research and Development, Sales and Marketing

Two key Pfizer executives are to step down as the company continues its drive to reinvigorate itself.The departures follow the …

Edelman scoops European Viagra account

May 23, 2007
Medical Communications

Pfizer has appointed PR agency Edelman to raise the European profile of its blockbuster erectile dysfunction treatment, Viagra.The company has …

Latest news from Datamonitor

May 23, 2007
Sales and Marketing

Breast cancer patients may be offered chemo-free treatmentHormone therapy drugs such as AstraZeneca's Zoladex may be as effective as traditional …

Med Ed comes of age

May 17, 2007
Medical Communications, Sales and Marketing medical education

Even a casual observer will have noticed the large contribution pharma makes to postgraduate medical education, both in the UK …

Roche selects Ketchum for pandemic work

May 17, 2007
Medical Communications

PR agency Ketchum has scooped a global account for Tamiflu as Roche begins further research into its use against bird …

The Gateway to Local Adoption Series

Latest content